The list is based on reports received by H. Lundbeck A/S from the company's executives today or yesterday. +-------------------------------------------------------------------+ | Name: | Claus Braestrup | | | | |---------------------------------------+---------------------------| | Job position of the executive: | CEO | | | | |---------------------------------------+---------------------------| | Relation to executive (associated | | | person or legal entity): | | | | | |---------------------------------------+---------------------------| | ID code (ISIN code): | DK 0010287234 | | | | |---------------------------------------+---------------------------| | Description of the security: | Share | | | | |---------------------------------------+---------------------------| | Nature of the transaction: | Sale of shares | | | | |---------------------------------------+---------------------------| | Date of trading: | 23 November 2007 | | | | |---------------------------------------+---------------------------| | Market on which the trading was | Copenhagen Stock Exchange | | effected: | | | | | |---------------------------------------+---------------------------| | Number of traded securities: | 7,800 | pcs. | | | | | |---------------------------------------+----------------+----------| | Market price of securities traded: | 1,146,600 | DKK | | | | | +-------------------------------------------------------------------+ Persons/entities under an obligation to report Persons or entities under an obligation to report are defined as members of the Executive Management and the Supervisory Board of H. Lundbeck A/S and persons/entities closely associated to them. Closely associated persons/entities means inter alia: * spouse or cohabitant * children below the age of 18 * legal entities in which the insider has a controlling influence The content of this release will have no influence on the Lundbeck Group's financial result for 2007. Lundbeck contacts Investors: Media: Jacob Tolstrup Anders Schroll Director, Corporate Reporting Head of Communication +45 36 43 30 79 +45 36 43 20 81 ________________________ Stock Exchange Release No 309 - 23 November 2007 About Lundbeck H. Lundbeck A/S is an international pharmaceutical company engaged in the research and development, production, marketing and sale of drugs for the treatment of psychiatric and neurological disorders. In 2006, the company's revenue was DKK 9.2 billion (approximately EUR 1.2 billion or USD 1.6 billion). The number of employees is approximately 5,300 globally. For further information, please visit www.lundbeck.com
Announcement of transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated persons and legal entities
| Source: H. Lundbeck A/S